Patient Perspectives on a Digital Mobile Health Application for RA.
adoption
digital health application
willingness to pay
Journal
Open access rheumatology : research and reviews
ISSN: 1179-156X
Titre abrégé: Open Access Rheumatol
Pays: New Zealand
ID NLM: 101688698
Informations de publication
Date de publication:
2021
2021
Historique:
received:
23
12
2020
accepted:
19
03
2021
entrez:
3
5
2021
pubmed:
4
5
2021
medline:
4
5
2021
Statut:
epublish
Résumé
Emerging evidence suggests that patients are increasingly willing to use digital mobile health applications for rheumatoid arthritis (RA apps). The development and diffusion of RA apps open the possibility of improved management of the disease and better physician-patient interactions. However, adoption rates among apps have been lower than hoped, and research shows that many available RA apps lack key features. There is little research exploring patient preferences for RA apps or patients' habits and preferences for app payment, which are likely key factors affecting adoption of this technology. This study seeks to understand characteristics of RA patients who have adopted RA apps, their preferences for app features, and their willingness to pay for, and experiences with app payment. Data for this study come from a 33-question online survey of patients with RA in Canada and the United States (N=30). Information on demographics, diagnosis and management of RA, current use and desired features of RA apps, and prior experience with and willingness to pay for an app was collected. Descriptive statistics are reported, and bivariate analyses (chi-square, point-biserial correlation, and ANOVA) were performed to understand relationships between variables. Respondents showed a clear preference for certain app features, namely symptom tracking, scheduling appointments, and reminders. Physician recommendation for an app and patient tracking of symptoms with an app were significantly related to patient adoption of an RA app. Years since diagnosis with RA, physician recommendation for an RA app, and current use of a non-RA health tracking app were significantly related to patients' willingness to pay a subscription for an RA app. RA patients appear to prefer task support features in an RA app, notably symptom tracking, appointment scheduling, and reminders, over other features such as those related to dialogue support and social support. The choice of whether an RA app will be free or based on a subscription, pay-per-service, or one-time purchase model may also play a role in eventual adoption. Similarly, physician recommendation appears to influence patients' decision to use an RA app as well as their willingness to pay a subscription for an app.
Sections du résumé
BACKGROUND
BACKGROUND
Emerging evidence suggests that patients are increasingly willing to use digital mobile health applications for rheumatoid arthritis (RA apps). The development and diffusion of RA apps open the possibility of improved management of the disease and better physician-patient interactions. However, adoption rates among apps have been lower than hoped, and research shows that many available RA apps lack key features. There is little research exploring patient preferences for RA apps or patients' habits and preferences for app payment, which are likely key factors affecting adoption of this technology. This study seeks to understand characteristics of RA patients who have adopted RA apps, their preferences for app features, and their willingness to pay for, and experiences with app payment.
METHODS
METHODS
Data for this study come from a 33-question online survey of patients with RA in Canada and the United States (N=30). Information on demographics, diagnosis and management of RA, current use and desired features of RA apps, and prior experience with and willingness to pay for an app was collected. Descriptive statistics are reported, and bivariate analyses (chi-square, point-biserial correlation, and ANOVA) were performed to understand relationships between variables.
RESULTS
RESULTS
Respondents showed a clear preference for certain app features, namely symptom tracking, scheduling appointments, and reminders. Physician recommendation for an app and patient tracking of symptoms with an app were significantly related to patient adoption of an RA app. Years since diagnosis with RA, physician recommendation for an RA app, and current use of a non-RA health tracking app were significantly related to patients' willingness to pay a subscription for an RA app.
CONCLUSION
CONCLUSIONS
RA patients appear to prefer task support features in an RA app, notably symptom tracking, appointment scheduling, and reminders, over other features such as those related to dialogue support and social support. The choice of whether an RA app will be free or based on a subscription, pay-per-service, or one-time purchase model may also play a role in eventual adoption. Similarly, physician recommendation appears to influence patients' decision to use an RA app as well as their willingness to pay a subscription for an app.
Identifiants
pubmed: 33935522
doi: 10.2147/OARRR.S296541
pii: 296541
pmc: PMC8080430
doi:
Types de publication
Journal Article
Langues
eng
Pagination
63-71Informations de copyright
© 2021 Chahal et al.
Déclaration de conflit d'intérêts
Simran Chahal and Norma Biln are employees of Augurex Life Sciences. Simran Chahal reports grants from National Research Council – Industry Research Assistance Program (NRC-IRAP) during the conduct of the study; Norma Biln reports grants from NRC-IRAP, during the conduct of the study. Bruce Clarke has no competing interests to declare.
Références
JMIR Mhealth Uhealth. 2018 Oct 29;6(10):e12221
pubmed: 30373732
JMIR Mhealth Uhealth. 2020 Aug 12;8(8):e19661
pubmed: 32678796
Rheum Dis Clin North Am. 2019 May;45(2):197-209
pubmed: 30952393
Rheum Dis Clin North Am. 2019 May;45(2):257-273
pubmed: 30952397
J Clin Rheumatol. 2019 Apr;25(3):133-141
pubmed: 29933327
JMIR Mhealth Uhealth. 2019 Nov 26;7(11):e14730
pubmed: 31769758
J Med Internet Res. 2021 Jan 29;23(1):e19998
pubmed: 33512320
JMIR Mhealth Uhealth. 2016 Oct 13;4(4):e118
pubmed: 27742604
JMIR Res Protoc. 2016 Nov 16;5(4):e219
pubmed: 27852561
Malays J Med Sci. 2018 Jul;25(4):122-130
pubmed: 30914854
JMIR Mhealth Uhealth. 2017 Feb 21;5(2):e7
pubmed: 28223263
JMIR Mhealth Uhealth. 2015 Mar 11;3(1):e27
pubmed: 25760773
Methods Inf Med. 2016;55(1):65-9
pubmed: 26391694
Rheumatology (Oxford). 2020 Feb 1;59(2):367-378
pubmed: 31335942
Pain Med. 2018 Mar 1;19(3):471-484
pubmed: 28541464
JMIR Mhealth Uhealth. 2019 Aug 05;7(8):e14991
pubmed: 31381501
Curr Rheumatol Rep. 2020 Nov 26;23(1):2
pubmed: 33244621
Rheumatology (Oxford). 2021 Jan 5;60(1):108-112
pubmed: 32572490